Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

PHASE3CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

May 9, 2023

Study Completion Date

May 9, 2023

Conditions
Mycobacterium Infections, Nontuberculous
Interventions
DRUG

ALIS

Inhalation via nebulization over approximately 6 to 15 minutes.

DRUG

Azithromycin

Oral tablet

DRUG

Ethambutol

Oral tablet

DRUG

ELC

Inhalation via nebulization over approximately 6 to 15 minutes.

Trial Locations (62)

116

TWN002, Taipei

613

TWN004, Chiayi City

807

TWN005, Kaohsiung City

3204

NZL002, Hamilton

4000

DNK001, Roskilde

4032

AUS010, Chermside

4040

AUT001, Linz

4102

AUS011, Woolloongabba

4122

NZL003, Hastings

5000

AUS008, Adelaide

8035

ESP003, Barcelona

8461

NZL001, Christchurch

11361

USA065, Bayside

13620

KOR005, Seongnam

17007

ESP005, Girona

20007

USA023, Washington D.C.

20162

ITA002, Milan

28034

ESP001, Madrid

28046

ESP004, Madrid

29414

USA024, Charleston

30625

GER007, Hanover

31326

USA029, Rincon

33707

USA014, St. Petersburg

33765

USA003, Clearwater

34362

ISR007, Haifa

34376

GER010, Immenhausen

34746

USA042, Kissimmee

41100

ITA006, Modena

51109

GER011, Cologne

52621

ISR004, Ramat Gan

53100

ITA008, Siena

66160

USA037, Kansas City

78100

ISR001, Ashkelon

80335

GER005, München

94305

USA050, Stanford

97239

USA025, Portland

4910000

ISR003, Petah Tikva

35233-1711

USA008, Birmingham

93701-2302

USA062, Fresno

92121-3018

USA048, San Diego

32207-8567

USA072, Jacksonville

34102-5444

USA039, Naples

33606-3603

USA067, Tampa

30912-0004

USA066, Augusta

21224-3057

USA017, Baltimore

63110-1035

USA061, St Louis

08844-1528

USA069, Hillsborough

10017-6739

USA011, New York

27710-0001

USA051, Durham

19104-4238

USA040, Philadelphia

29621-5708

USA044, Anderson

37067-5603

USA022, Franklin

75069-8085

USA021, McKinney

75708-3154

USA052, Tyler

X5003DCE

ARG003, Córdoba

DK-9000

DNK004, Aalborg

DK-8200

DNK002, Aarhus

01307

GER006, Dresden

00168

ITA005, Rome

05505

KOR002, Seoul

06973

KOR003, Seoul

08003

ESP002, Barcelona

All Listed Sponsors
lead

Insmed Incorporated

INDUSTRY

NCT04677543 - Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex | Biotech Hunter | Biotech Hunter